Phoenix Wealth Advisors Has $984,000 Stock Position in Danaher Co. (NYSE:DHR)

Phoenix Wealth Advisors reduced its stake in Danaher Co. (NYSE:DHR) by 1.3% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 4,287 shares of the conglomerate’s stock after selling 56 shares during the period. Phoenix Wealth Advisors’ holdings in Danaher were worth $984,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also made changes to their positions in DHR. FMR LLC boosted its position in shares of Danaher by 15.8% in the 3rd quarter. FMR LLC now owns 23,617,424 shares of the conglomerate’s stock worth $6,566,116,000 after purchasing an additional 3,217,631 shares during the last quarter. Massachusetts Financial Services Co. MA boosted its position in shares of Danaher by 17.6% in the 3rd quarter. Massachusetts Financial Services Co. MA now owns 3,582,982 shares of the conglomerate’s stock worth $996,141,000 after purchasing an additional 535,254 shares during the last quarter. International Assets Investment Management LLC boosted its position in shares of Danaher by 40,196.5% in the 3rd quarter. International Assets Investment Management LLC now owns 429,964 shares of the conglomerate’s stock worth $119,539,000 after purchasing an additional 428,897 shares during the last quarter. Montrusco Bolton Investments Inc. boosted its position in shares of Danaher by 30.4% in the 3rd quarter. Montrusco Bolton Investments Inc. now owns 1,705,884 shares of the conglomerate’s stock worth $465,617,000 after purchasing an additional 397,671 shares during the last quarter. Finally, Caisse DE Depot ET Placement DU Quebec boosted its position in shares of Danaher by 82.4% in the 3rd quarter. Caisse DE Depot ET Placement DU Quebec now owns 653,375 shares of the conglomerate’s stock worth $181,651,000 after purchasing an additional 295,187 shares during the last quarter. 79.05% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

DHR has been the topic of several recent research reports. Raymond James reduced their price target on Danaher from $300.00 to $275.00 and set an “outperform” rating on the stock in a research report on Tuesday. Guggenheim started coverage on Danaher in a report on Thursday, December 19th. They set a “buy” rating and a $275.00 target price on the stock. Evercore ISI lifted their target price on Danaher from $275.00 to $278.00 and gave the stock an “outperform” rating in a report on Tuesday, October 1st. Bank of America upgraded Danaher from a “neutral” rating to a “buy” rating and set a $290.00 target price on the stock in a report on Friday, December 13th. Finally, UBS Group reduced their target price on Danaher from $309.00 to $305.00 and set a “buy” rating on the stock in a report on Wednesday, October 23rd. Six investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $285.55.

Danaher Price Performance

NYSE:DHR opened at $244.18 on Wednesday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.01 and a current ratio of 1.37. The stock’s 50-day simple moving average is $234.84 and its 200 day simple moving average is $253.53. The company has a market cap of $176.36 billion, a P/E ratio of 46.60, a P/E/G ratio of 4.30 and a beta of 0.83. Danaher Co. has a 52-week low of $225.42 and a 52-week high of $281.70.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share for the quarter, topping analysts’ consensus estimates of $1.57 by $0.14. The firm had revenue of $5.80 billion for the quarter, compared to the consensus estimate of $5.59 billion. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The business’s revenue was up 3.1% compared to the same quarter last year. During the same quarter in the previous year, the business earned $2.02 earnings per share. As a group, sell-side analysts forecast that Danaher Co. will post 7.49 EPS for the current fiscal year.

Danaher Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Friday, December 27th will be given a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a yield of 0.44%. The ex-dividend date is Friday, December 27th. Danaher’s dividend payout ratio (DPR) is presently 20.61%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.